CVI Holdings’s Milestone Scientific MLSS Stock Holding History

CVI Holdings’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-374,765	Closed	-$731K	–	108
2020 Q2	$731K	Buy	+374,765	New	+$686K	0.27%	39

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CVI Holdings's MLSS Position: Q3 2020 in Review

CVI Holdings sold out of Milestone Scientific (MLSS) in Q3 2020, closing a stake of 374,765 shares — an estimated $731K sold.

CVI Holdings first reported a position in MLSS in Q2 2020 and held it in 1 quarter. The position peaked at $731K in Q2 2020. 47 funds tracked by Wall St. Rank hold MLSS as of Q3 2020.

CVI Holdings reported no remaining Milestone Scientific position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 374,765 Milestone Scientific shares in Q3 2020, an estimated $731K.
CVI Holdings first reported a position in Milestone Scientific in Q2 2020 and held it in 1 quarter.
CVI Holdings's Milestone Scientific position peaked at $731K in Q2 2020.
47 funds tracked by Wall St. Rank held Milestone Scientific as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.